Duquesne Capital Management
7
45M
6
0.16
1
0.14
5
- Areas of investment
Summary
Duquesne Capital Management appeared to be the VC, which was created in 1981.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Duquesne Capital Management, startups are often financed by Talu Ventures, Motorola Solutions Venture Capital, Deutsche Bank. The meaningful sponsors for the fund in investment in the same round are Galleon Group, Tollgrade Communications, Telkonet. In the next rounds fund is usually obtained by Morgan Stanley, International Finance Corporation, Innovation Works.
Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this Duquesne Capital Management performs on 71 percentage points more the average number of lead investments. The top amount of exits for fund were in 2007. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2007. The common things for fund are deals in the range of 50 - 100 millions dollars.
The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Digital Media. Among the most popular portfolio startups of the fund, we may highlight FibroGen, Dilithium Networks, BPL Global.
Investments analytics
Analytics
- Total investments
- 7
- Lead investments
- 1
- Exits
- 5
- Rounds per year
- 0.16
- Follow on index
- 0.14
- Investments by industry
- Pharmaceutical (4)
- Biotechnology (3)
- Health Diagnostics (1)
- Health Care (1)
- Medical (1) Show 8 more
- Investments by region
-
- United States (7)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 64M
- Group Appearance index
- 1.00
- Avg. company exit year
- 9
- Avg. multiplicator
- 1.17
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ratio Therapeutics | 17 Jan 2024 | Pharmaceutical | Early Stage Venture | 50M | United States, Massachusetts, Boston |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.